What's new? Log in Free sign up

Latest news and press releases

News

From Benzinga Pro

Tenable Vulnerability Management And Tenable Web App Scanning, Have Been Successfully Assessed At A Protected Level By The Information Security Registered Assessors Program In Australia

Tenable® , the Exposure Management company, today announced that two of its solutions, Tenable Vulnerability Management and Tenable Web App Scanning, have been successfully assessed at a 'PROTECTED' level by

A Look At Upcoming IPOs For The Week

With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.

Mark Cuban Shares Three Supplements He Takes To Keep Himself Sharp

News, Health Care, Top Stories, General

With all of his many ventures, Mark Cuban, the celebrated billionaire investor who is set to sell a majority stake in the Dallas Mavericks, reportedly keeps to a routine to stay on top of his game. </

Cigna Drops Humana Merger, Opts For $10 Billion Buyback Strategy

M&A, News, Health Care, Top Stories, General

In a recent development in the health insurance sector, Cigna Corporation (NYSE: CI) has withdrawn from its proposed merger with Humana Inc. (NYSE:

Trump Fires Back At Biden, Accuses Democrats Of Making Hoaxes Against Him: 'I Will Save Democracy. The Threat Is Crooked Joe Biden'

News, Politics, Top Stories, General

In a recent gathering with the New York Young Republican Club, former President Donald Trump strongly dismissed claims that his potential 2024 presidential candidacy would endanger American democracy.

Tech Enthusiasts, Looking For The Perfect Holiday Gift? Munster Has These Recommendations For You

Analyst Color, News, Top Stories, Tech

With the holiday season in full swing, Gene Munster's Deepwater Asset Management has offered its annual gift ideas.

C-Suite Exodus At Tesla? After Dojo Supercomputer Lead's Rumored Exit, AI Infra Head Tim Zaman Jumps Ship To Google's DeepMind

Equities, News, Management, Top Stories, Tech

Tesla has lost two key executives in a span of two months, stirring concerns regarding potential delays to its automotive driving tech.

The Cigna Group Confirmed Increase To Share Repurchase Program Of $10B

Global health company The Cigna Group (NYSE:CI) today announced that its Board of Directors has approved an aggregate increase of $10 billion in incremental share repurchase authorization, bringing the company's

Centessa Pharmaceuticals Announced New Data From Additional 52-Weeks of Continuous Treatment From Third Year (Part 5) Of Ongoing Phase 2a Study Of SerpinPC For Treatment Of Hemophilia At 2023 ASH Meeting

Centessa Pharmaceuticals plc (NASDAQ:CNTA), today announced new data from an additional 52-weeks of continuous treatment from the third year (Part 5) of the ongoing Phase 2a study of SerpinPC for the treatment of

Molecular Partners Presented Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial Of MP0533 For Patients With Relapsed/Refractory AML And AML/MDS At 2023 ASH Meeting

Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today presented positive initial clinical data from its

Regeneron Announced Sunday Updated Odronextamab Data From Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep And Durable Responses And Potential Of ctDNA To Predict Long-term Outcomes At 2023 ASH Meeting

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced new and updated data for odronextamab in patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). The data from the pivotal Phase 2

Belite Bio Received Approval To Initiate Tinlarebant Phase 3 Clinical Trial For GA in Switzerland

Belite Bio, Inc (NASDAQ:BLTE), a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting retinal degenerative eye diseases which have significant unmet medical needs,

Cigna No Longer Pursuing Tie-Up With Humana; Two Sides Couldn't Agree on Terms

-The Wall Street Journal, Citing Sources-The Wall Street Journal, Citing Sources https://www.wsj.com/business/deals/cigna-calls-off-humana-pursuit-plans-big-stock-buyback-ae1c6b3c?mod=hp_lead_pos1

Coca Leaf Ventures: Mapping Pharma & Nutraceuticals, Value Chain And Investment Opportunities

Cannabis, News, Psychedelics, Health Care, Management, Exclusives, Markets, Interview

Despite the stigma, the coca plant is effectively entering the drug reform movement as part of an expected “third wave of decriminalization” along with other controlled substances including psychedelics.

Supreme Court Settlement Paves Way For New York Medical Marijuana Shops To Enter Adult Market On Dec. 29

Cannabis, Government, News, Regulations, Retail Sales, Markets

Following a months-long legal standoff that had New York cannabis shop owners in a holding pattern and state regulators unable to hand out new business licenses, the doors are finally opening.

Trump Reveals Who He Thought Won Latest GOP Debate: 'Who On This Subject Would Be Better Than Me'

News, Politics, Top Stories, General

Amid a seemingly uncompetitive Republican presidential race, former President Donald Trump shared his insights on the latest GOP debate.

LSD And Psilocybin Could Outperform Opioids For Pain, Without Developing Tolerance, New Study Says

Cannabis, Psychedelics, Markets, General

This article was originally published on Psychedelic Spotlight and appears here with permission.

High Hanukkah: 3 Ways To Infuse Your Hanukkah Recipes With Cannabis

Cannabis, Markets, General

This article was originally published on Leafly and appears here with permission.

In Controversial Move, Elon Musk Reinstates Far-right Conspiracy Theorist Alex Jones' Account: 'The People Have Spoken And So It Shall Be'

News, Social Media, General

Elon Musk has reinstated the account of right-wing extremist Alex Jones on X, reversing the platform's previous ban on Jones in 2018 for his repeated violations of policies against harassment and hate speech.<

Sanofi And Minapharm Sign Exclusive Agreement For Localizing The manufacture Of Clexane

News, Contracts

Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®. The agreement between Sanofi, a

Bristol Myers Squibb On Saturday Presented Primary Efficacy, Safety Analysis of the Phase 3 COMMANDS Trial Of Reblozyl For Treatment Of Anemia In Erythropoiesis Stimulating Agent-Naïve Patients With Lower-Risk Myelodysplastic Syndromes At 2023 ASH Meeting

Top Crypto Analyst Willy Woo Makes Bull And Bear Cases For Bitcoin

Cryptocurrency, Markets

FibroGen Presented Data From Phase 3 MATTERHORN Trial Of Roxadustat In Patients With Anemia Of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes At 2023 ASH Meeting

Biomea Fusion Announced Saturday Near Doubling The Percentage Of Patients With Durable HbA1c Reduction In the 200 mg Dose Cohorts

Solana-based Debutant JITO Exceeds $1.1B In Single-day Trading Volume

Cryptocurrency, Markets

Aptose Tuspetinib Clinical Data Featured In Oral Presentation Saturday At 2023 ASH Meeting; Said TUS/VEN Combination Active Across Broad Populations Of AML And Demonstrates 25% Complete Response Rate Among All-comers, Including 20% CRc In Wildtype AML

The Ultimate Guide To Christmas Movie Streaming: Best Services And Setup Tips

Agios Presented Results Saturday From Phase 2 Portion Of RISE UP Pivotal Study In Sickle Cell Disease At ASH Meeting; Said Treatment With Mitapivat Demonstrated Statistically Significant Improvement In Hemoglobin Response Compared To Placebo

Pfizer Announced Saturday Marstacimab Phase 3 Data Presented At ASH 2023 Demonstrate Significant Bleed Reduction In Hemophilia A And B

Autolus Therapeutics Presented Clinical Data Updates Saturday At 2023 ASH Meeting

Press releases

From Benzinga Pro

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX

NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SCYNEXIS, Inc. (NASDAQ:SCYX) between March 31, 2023 and September 22, 2023, both

COP28: Canada Daily Highlights - December 10, 2023

Commodities, Press Releases

DUBAI, United Arab Emirates, Dec. 10, 2023 /CNW/ - Daily event and announcement summary Today, the

Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size Projected to Reach US$ 45.51 Billion by 2034: Fact.MR Study

Rockville , Dec. 10, 2023 (GLOBE NEWSWIRE) -- Expanding at 6.2% CAGR from 2024 to 2034, the global attention deficit hyperactivity disorder (ADHD) therapeutics market is estimated to reach a valuation of US$ 45.51

Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease

- Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment - Data are featured in the Plenary

ROSEN, A LONGSTANDING LAW FIRM, Encourages Generac Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GNRC

News, Legal, Press Releases

NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Generac Holdings Inc. (NYSE:GNRC) between May 3, 2023 and August 3, 2023, both

MVST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Microvast Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

News, Legal, Press Releases

SAN DIEGO, Dec. 10, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Microvast Holdings, Inc. (NASDAQ:MVST, MVSTW)) securities between October 19,

ONE Announces Manufacturing Veteran and Founding Board Member, Paul Humphries as New CEO

NOVI, Michigan, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Founder Mujeeb Ijaz becomes Vice-Chairman and Chief Technology Officer (CTO).Experienced investor and founding board member Faysal Sohail appointed Chairman of the

ACADIA SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) and Encourages Long-Term ACAD Investors to Contact the Firm

News, Legal, Press Releases

PHILADELPHIA, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Acadia Pharmaceuticals Inc. ("Acadia") (NASDAQ:ACAD) on behalf the company's long-term investors. Recently an amended

EHANG ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In EHang To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 investing in EHang stock or options between January 20, 2022 and November 6, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson

Statement to mark the end of the 16 Days of Activism Against Gender-Based Violence

OTTAWA, ON, Dec. 10, 2023 /CNW/ - The Honourable Marci Ien, Minister for Women and Gender Equality and Youth, issued the following statement for Human Rights Day, which also marks the final day of the 16 Days of Activism

Taiho Oncology Announces Presentation of Data From a U.S. Real-Word Study of Oral Decitabine and Cedazuridine

Retrospective analysis of patients with myelodysplastic syndromes showed trends in treatment patterns that suggest:improved trend persistence with oral decitabine and cedazuridine versus intravenous/subcutaneous

Morrow Sodali Acquires Australian Corporate Communication Consultancy, Domestique

Leading Global Stakeholder Engagement Advisory Firm Expands APAC Business, Advancing Strategy in Partnership with TPG Morrow Sodali (the "Firm"), a global leader in stakeholder engagement advisory services, is pleased

Inversionista.Academy Expands Horizons, Launches Trading Education Courses in Latin America

London, United Kingdom, December 11, 2023- Inversionista.Academy proudly announces its expansion into Latin America with the launch of a state-of-the-art trading education platform, aimed at empowering aspiring traders

Philanthropist Rosario S. Cassata, of The Cassata Foundation, Donates Gifts and Toys to 40 Local Children and Families

News, Politics, Retail Sales, Press Releases

Huntington, NY December 10, 2023 --(PR.com)-- Rosario S. Cassata and his wife, Carolyn, of The Cassata Foundation, hosted its Annual Event, "Shop with a Cop," along with Officer Delgado of the Suffolk County

Belgium and Lockheed Martin Celebrate Rollout of First F-35A for Belgium

FORT WORTH, Texas, Dec. 10, 2023 /PRNewswire/ -- Lockheed Martin [LMT] presented Belgium's first F-35A Lightning II to the Belgian government during a rollout ceremony at Lockheed Martin's F-35 production

Good Banks and Stellar Customer Service: 3D Chess Media Reveals Online Leaders in the Digital Age

Online banks are raising the bar when it comes to customer service, with many prioritizing 24/7 support, comprehensive FAQs, chatbots, and other innovative support mechanisms.Las Vegas, NV--News Direct--The rise of

At COP28, momentum increases for the Global Carbon Pricing Challenge

Commodities, Press Releases

DUBAI, United Arab Emirates, Dec. 10, 2023 /CNW/ - Carbon pricing is most effective when more countries adopt it—broader coverage means more opportunities to find clean solutions. Through international cooperation,

Government of Canada announces new economic incentive to reduce methane emissions from beef cattle

Commodities, Press Releases

GATINEAU, QC, Dec. 10, 2023 /CNW/ - Against the backdrop of Food and Agriculture Day at COP28, the global community is witnessing a pivotal moment in the collective effort to address environmental challenges within the

Epicenter of Healthcare Transformation: The Intelligent Health Association's 2023 International Summit starts tomorrow, Monday, December 11

Igniting a New Era of Medical Excellence: Pioneering Insights and Breakthrough Innovations at the Forefront of Global HealthNew York, NY--News Direct--In an era where technological evolution is pivotal to healthcare

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SunPower Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPWR

NEW YORK, Dec. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SunPower Corporation (NASDAQ:SPWR) between March 9, 2023 and October 24, 2023,

Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor During Oral Presentation at 2023 American Society of Hematology (ASH) Annual Meeting

Empowering the Season of Giving: Annual Holiday Canteen Drive Brings Aid to Incarcerated Women

Applicants Wanted: The Fighting and Managing Wildfire in a Changing Climate Program - Training Fund

Commodities, Press Releases

The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion

SAMARITAN'S PURSE DEPLOYS ASSESSMENT TEAM TO TENNESSEE AFTER DEADLY TORNADOES

ROSEN, SKILLED INVESTOR COUNSEL, Encourages James River Group Holdings, Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – JRVR

News, Legal, Press Releases

/R E P E A T -- NOTICE TO THE MEDIA - Government of Canada to make an announcement on oral health care for Canadians/

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term Outcomes

Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia

Health Care, Press Releases

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.